AVDL 10.31 (+1.98%)
US05337M1045Drug ManufacturersDrug Manufacturers - Specialty & Generic

Avadel Pharmaceuticals (AVDL) Stock Highlights

10.31 | +1.98%
2024-12-21 03:57:32
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States.

Statistics

Range Today
9.98 10.53
Volume Today 1.17M
Range 1 Year
9.41 19.09
Volume 1 Year 298.18M
Range 3 Year
1.05 19.09
Volume 3 Year 841.65M
Range 10 Year
1.03 26.09
Volume 10 Year 1.52B

Highlights

Market Capitalization 1.53B (small)
Floating Shares 83.23M
Current Price 10.31
Price To Earnings -14.42
Price To Revenue 15.77
Price To Book 21.81
Earnings Per Share -1.09
Payout Ratio 0%

Performance

Latest +1.98%
1 Month -3.73%
3 Months -24.41%
6 Months -33.53%
1 Year -26.36%
3 Years +38.02%
5 Years +64.96%
10 Years -45.74%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.